You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs

Article info

Article menu
Download PDFPDF
Letters
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs

Authors

  • E H Vogelzang Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • M F Pouw Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • M Nurmohamed Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • E L Kneepkens Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • T Rispens Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • G J Wolbink Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • C L M Krieckaert Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Erik Hans Vogelzang, Jan van Breemen Research Institute|Reade, Dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands; e.vogelzang{at}reade.nl
View Full Text

Citation

Vogelzang EH, Pouw MF, Nurmohamed M, et al
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs
Annals of the Rheumatic Diseases 2015;74:474-475.

Publication history

  • Received September 7, 2014
  • Accepted November 9, 2014
  • First published November 28, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions